X
spot_img
Supported byspot_img

Pharmaceutical Industry

pharma

Healthy Investment

 

  • – The value of sector annual production is Eur 308 mill.
  • – Generic drugs development strategy
  • – Cost efficiency & intellectual capacities
  • – Market potentials & commitment to quality

 

Supported by

Serbia Business produced several briefs on market status covering producers, distributors and local outsourced partners. Pharma sector in Serbia is one of the most perspective business areas.

Serbia Business also produced 2011/2010 pharma sector market report.

More on sector opportunities

Suppported byOwner's Engineer
Previous article
Next article

Bankruptcy process initiated for shipyard in Zrenjanin

The Commercial Court in Zrenjanin has issued a ruling approving the proposal to initiate bankruptcy proceedings for the shipyard Brodogradilište LBM, based in the...

President discusses global challenges and economic cooperation with Chinese Vice Premier

"It is a great honor to have the opportunity to meet with the Vice Premier of the People's Republic of China at such a...

Serbia signs 70 million euro loan agreement with KfW bank for water and wastewater projects

Serbia has secured a loan of 70 million euros from the German KfW bank to finance a program aimed at improving water supply efficiency...
Supported byspot_img
Supported byspot_img
Supported byspot_img
error: Content is protected !!